These DNA modifications can affect a person's susceptibility to developing rheumatoid arthritis. For example, distinct marker patterns have been observed in affected twins compared to unaffected twins, highlighting the role of epigenetics in predisposition to this condition.
Furthermore, the article provides important information about the mechanisms that lead from mucositis to clinical disease. Smoking and genetic risks, when combined, can significantly increase the risk of developing rheumatoid arthritis.
Inflammation and stress on mucosal surfaces, especially in the bronchial tubes, are important in the development of the disease.
However, despite advances in understanding the mechanisms underlying rheumatoid arthritis, challenges remain. The transition from preclinical rheumatoid arthritis to established disease remains a question mark. While many therapeutic interventions have been tested, including so-called breakthrough therapies, none have been able to completely prevent clinical disease progression.
Ultimately, a deeper understanding of the genetic and environmental origins of RA is critical for developing effective prevention and treatment strategies.
Continued investigations in this area are crucial to improve the management of this debilitating condition and improve the quality of life of affected patients. However, we should not delegate this responsibility exclusively to medical science. Each of us must take an active role in this battle by adopting healthy habits in order to increase our chances of fighting not only rheumatoid arthritis, but also other chronic diseases.
